Author:
Riyahi Niknam,Reza Saadatzadeh M.,Bijangi-Vishehsaraei Khadijeh,Barghi Farinaz,H. Pandya Pankita,E. Pollok Karen
Abstract
DNA repair pathway is considered to be one of the most important mechanisms that protect cells from intrinsic and extrinsic stresses. It has been established that DNA repair activity has a crucial role in the way that cancer cells respond to treatment. Sarcomas are a group of tumors with mesenchymal origin in which their association with DNA repair aberrations has been reported in numerous studies. Special attention has been focused on exploiting these alterations to improve the patient’s overall survival and overcome drug resistance in cancer. While there is a large degree of heterogeneity among different types of sarcomas, DNA repair alteration is found to be a common defect in the majority of patients. In this chapter, we will introduce and review some of the most important dysregulated components involved in the DNA repair system, and discuss their association with tumorigenesis, cancer aggressiveness, drug resistance, and overall prognosis in the patients with sarcomas.
Reference138 articles.
1. Nacev BA, Jones KB, Intlekofer AM, Jamie S, Allis CD, Tap WD, et al. The epigenomics of sarcoma. Nature Reviews Cancer. 2020:1-16
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69(1):7-34
3. Reed DR, Naghavi A, Binitie O. Sarcoma as a model for adolescent and young adult care. Journal of oncology practice. 2019;15(5):239-247
4. Nathenson MJ, Conley AP, Sausville E. Immunotherapy: a new (and old) approach to treatment of soft tissue and bone sarcomas. The oncologist. 2018;23(1):71
5. Hatina J, Kripnerova M, Houfkova K, Pesta M, Kuncova J, Sana J, et al. Sarcoma stem cell heterogeneity. Stem Cells Heterogeneity-Novel Concepts: Springer; 2019. p. 95-118.